What does the company do?
Novartis AG, incorporated on February 29, 1996, is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products. The Company’s healthcare solutions portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Its businesses are divided on a worldwide basis into the four operating divisions: Pharmaceuticals, which comprises brand-name patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; Sandoz, which consists generic pharmaceuticals, and Consumer Health, which includes over-the-counter medicines, animal health medicines, and contact lenses and lens-care products. It operates in approximately 140 countries. In September 2009, Novartis AG announced that its Sandoz division has completed the acquisition of EBEWE Pharma's specialty generic injectables business.
How much does the company sell and earn?
Investors need to know how much stuff or services a company sells, and how much of that total it keeps as income (or profit) to grow its business or return to shareholders. The more of each, the better. In general, look for companies that sell and earn more than peers.
- Novartis AG one-year sales: 42.31 Bil.
Difference from the average for the Drug Manufacturers - Major group: 1.17% - Novartis AG one-year income: 7.59 Bil.
Difference from the average for the Drug Manufacturers - Major group: 1.94%| Sales & Income (past 12 months) | Company | Industry |
|---|
| Sales | 42.31 Bil | 41.82 Bil | | Income | 7.59 Bil | 7.45 Bil |
How fast is the company growing?
- Novartis AG one-year sales growth: -0.90%.
- Novartis AG one-year income growth: -8.00%.
| Sales & Income Growth (past 12 months) | Company | Industry |
|---|
| Sales Growth | -0.90% | 1.40% | | Income Growth | -8.00% | 5.30% |
How profitable is the company?
Investors prefer companies that increase profit margins -- the percentage of sales that they keep -- every year. This is accomplished either by lowering expenses or raising prices. Look for companies that consistently find ways to squeeze more profits out of sales than their peers.
- Novartis AG one-year net profit margin: 18.0%
Difference from the company's 5-year average net profit margin: -0.9 pct. pts.
Difference from the average for the Drug Manufacturers - Major group: -0.6 pct. pts.
| Net profit margins (%) |
|---|
| Company | 18.0% | | Company 5-Yr Avg. | 18.9% | | Industry | 18.6% |
How is the company's financial health?
The debt/equity ratio shows how much a firm has borrowed as a percentage of its stock equity. The lower, the better.
- Novartis AG debt/equity ratio: 0.27.
Difference from the average for the Drug Manufacturers - Major group: -88.16%.
| | Company | Industry |
|---|
| Debt/equity ratio | 0.27 | 2.28 |
|
Recent News